Author By adminPosted on September 20, 2023April 7, 2024 CBP-1019 has received FDA Orphan Drug Designation Coherent Biopharma announced today that their proprietary second-generation dual-ligand conjugate drug, CBP-1019, has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) on …
